These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26131997)

  • 1. How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Gebhard A; van den Hof S; Cobelens F
    Am J Respir Crit Care Med; 2015 Jul; 192(1):117. PubMed ID: 26131997
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
    Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Am J Respir Crit Care Med; 2015 Jul; 192(1):117-8. PubMed ID: 26131996
    [No Abstract]   [Full Text] [Related]  

  • 3. Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?
    Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Am J Respir Crit Care Med; 2015 Feb; 191(3):355-8. PubMed ID: 25635495
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 5. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Joint Statement on the New WHO Recommendations for Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis].
    Maurer FP; Bauer T; Diel R; Häcker B; Lange C; Niemann S; Otto-Knapp R; Schönfeld N
    Pneumologie; 2019 May; 73(5):270-273. PubMed ID: 31083750
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-resistant Mycobacterium tuberculosis, Taiwan.
    Jou R; Chuang PC; Wu YS; Yan JJ; Luh KT
    Emerg Infect Dis; 2006 May; 12(5):871-2. PubMed ID: 16710962
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.
    Mitchell SL; Seoudi N; Hutchison DC; Drobniewski FA
    Thorax; 2011 Jul; 66(7):630-1. PubMed ID: 20880876
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug susceptibility of tuberculosis isolates in Kansas, 1992-1993.
    Kans Med; 1994 Jun; 95(6):147-8. PubMed ID: 7933767
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the prevalence of Mycobacterium tuberculosis resistance is not that easy: the interest and limits of a retrospective survey.
    Chaulet P
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1077. PubMed ID: 11769763
    [No Abstract]   [Full Text] [Related]  

  • 11. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing drug-resistant tuberculosis: experiences from India.
    Katoch VM
    Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676
    [No Abstract]   [Full Text] [Related]  

  • 13. [The resistance status of Mycobacterium tuberculosis in Austria 1992 and 1993].
    Stauffer F; Jaksch G
    Wien Klin Wochenschr; 1995; 107(15):470-1. PubMed ID: 7676686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic observation drug susceptibility (MODS): where are we going?
    Kam KM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):127. PubMed ID: 24429301
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.
    Arora J; Sidiq Z; Visalakshi P; Bhalla M; Behera D; Myneedu VP
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):380-1. PubMed ID: 24075630
    [No Abstract]   [Full Text] [Related]  

  • 16. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

  • 17. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
    [No Abstract]   [Full Text] [Related]  

  • 18. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?
    Chang KC; Yew WW; Zhang Y
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29269428
    [No Abstract]   [Full Text] [Related]  

  • 20. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.